ID   UPSFRi004-A-1
AC   CVCL_C348
SY   PB05-1; PB05.1; UPS-FRi006-A; UPSFRi003-A
DR   hPSCreg; UPSFRi004-A-1
DR   SKIP; SKIP002388
DR   Wikidata; Q54991766
RX   PubMed=22425713;
CC   From: Universite Paris-Sud 11; Paris; France.
CC   Derived from site: In situ; Amniotic fluid; UBERON=UBERON_0000173.
CC   Cell type: Amniocyte; CL=CL_0002323.
DI   NCIt; C34375; Beta thalassemia
DI   ORDO; Orphanet_231214; Beta-thalassemia major
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C347 ! UPSFRi004-A
SX   Male
AG   Fetus
CA   Induced pluripotent stem cell
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 15
//
RX   PubMed=22425713; DOI=10.1016/j.ajpath.2012.01.011;
RA   Griscelli F., Feraud O., Oudrhiri N., Gobbo E., Casal I.,
RA   Chomel J.-C., Bieche I., Duvillard P., Opolon P., Turhan A.G.,
RA   Bennaceur-Griscelli A.;
RT   "Malignant germ cell-like tumors, expressing Ki-1 antigen (CD30), are
RT   revealed during in vivo differentiation of partially reprogrammed
RT   human-induced pluripotent stem cells.";
RL   Am. J. Pathol. 180:2084-2096(2012).
//